Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
NextGen Biomed 2025 Light Logo

12 - 14 March 2025 | London, UK

Welcome to NextGen Biomed

You’ve seen the highlights—now it’s time to secure your place.

Join 1,000+ leaders from pharma, biotech, regulatory, and academic sectors for an unmatched opportunity to advance your knowledge and expand your network. With six programmes covering biologics, immunotherapy, vaccines, peptides, and more, you’ll gain crucial insights into the next wave of biomedicine.

Don’t miss 50 hours of content, 200 presentations, 12+ hours of networking, and exclusive social events like our Day 1 drinks reception hosted by The Antibody Society and Day 2 Science Museum Dinner. These are the moments designed to foster connections and accelerate your projects.

 85% of Passes Already Sold - Secure Yours Today!

Explore the NextGen Biomed 2025 Programme

NextGen Biomed 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

Proteins, Antibodies & ADCs
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?

Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow; and Lundbeck Andrew Buchanan, Principal Scientist, AstraZeneca

Peptides
Roundtable: Regulatory Insights On Bringing A Peptide To Human Trials

Moderator: Paul Reid, Co-Founder & Chief Scientific Officer, Celtic Bio

Oligonucleotides
Workshop: Development Of Targeted Delivery Systems

Two Presentations, followed by a Panel Discussion on 'The Next Chapter Of Oligonucleotide Delivery'
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK

Sustainability in Tides & Biologics
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches

Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna

Immunotherapy & Immuno-oncology
Presentation: How The RNA Technologies Could Help To Prevent Infectious Diseases And Could Be Applied To Various Chronic Disease Immunotherapies?

Presented by: Daniel Larocque, Innovation Lead, Innovation and Emerging Science, Sanofi

2025 Sponsors Include

Hurry! Over 85% Of Passes Already Sold

  •  
  • *Complimentary passes are for Pharma and Biotech R&D professionals only (excludes solution providers and tech companies).